GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ZYUS Life Sciences Corp (OTCPK:ZLSCF) » Definitions » 3-Year EBITDA Growth Rate

ZLSCF (ZYUS Life Sciences) 3-Year EBITDA Growth Rate : 0.00% (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ZYUS Life Sciences 3-Year EBITDA Growth Rate?

ZYUS Life Sciences's EBITDA per Share for the three months ended in Sep. 2024 was $-0.03.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Competitive Comparison of ZYUS Life Sciences's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, ZYUS Life Sciences's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ZYUS Life Sciences's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ZYUS Life Sciences's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where ZYUS Life Sciences's 3-Year EBITDA Growth Rate falls into.


;
;

ZYUS Life Sciences 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


ZYUS Life Sciences  (OTCPK:ZLSCF) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


ZYUS Life Sciences 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of ZYUS Life Sciences's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


ZYUS Life Sciences Business Description

Traded in Other Exchanges
Address
407 Downey Road, Unit 204, Saskatoon, SK, CAN, S7N 4L8
ZYUS Life Sciences Corp is primarily engaged in the global development and commercialization of innovative cannabinoid-based therapeutics and product candidates. It is a licensed producer and distributor of medical cannabis for both medical and adult recreational access in Canada.

ZYUS Life Sciences Headlines

No Headlines